Bell Potter Securities

Arafura Resources Limited is an Australian company focused on exploring and developing mineral properties, particularly rare earth deposits, along with tungsten, copper, and vanadium. The company's flagship project is the Nolans project, a significant rare earths-phosphate-uranium-thorium deposit located in the Northern Territory, which primarily supplies neodymium and praseodymium products. Established in 1997 and based in Perth, Arafura Resources also engages in mining activities, infrastructure development, and conducting social and environmental feasibility evaluations to ensure responsible resource management.

Credit Clear Ltd is a financial services company that specializes in providing innovative debt resolution solutions through a digital engagement platform. The company offers a comprehensive collections management service that includes both collections and legal expertise. Utilizing advanced technology, including a machine learning engine, Credit Clear enhances the collections process by profiling customers, automating optimal contact times for payment requests, and delivering tailored messaging. This approach allows Credit Clear to replace traditional billing systems with digital and actionable invoices, streamlining communication and payment processes. The majority of its revenue is generated from the collections segment, primarily within the Australian market.

Agersens, established in 2014 and based in Camberwell, Australia, is a technology company specializing in livestock management solutions. It develops the eShepherd system, comprising an animal collar and a smartphone application, which enables farmers to automate the movement and control of their livestock, such as beef and dairy cattle, sheep, and other animals, without the need for physical fences. This technology allows farmers to create virtual fences, improving farm productivity, animal welfare, and reducing labor costs. Agersens serves large-scale beef producers, dairy farmers, natural resource managers, and researchers, offering them a modern, efficient, and flexible way to manage their livestock.

Osprey Medical, Inc. is a medical device company headquartered in Minnetonka, Minnesota, that specializes in technologies aimed at reducing the harmful effects of contrast dye used during angiographic imaging procedures. Founded in 2005, the company has developed a range of products, including the AVERT and DyeVert systems, designed to minimize the volume of contrast injected into patients during cardiovascular and peripheral procedures. Osprey Medical's proprietary CINCOR™ System is specifically focused on preventing Contrast Induced Nephropathy (CIN), leveraging technology originally developed at the Baker Heart and Diabetes Institute in Australia. The company's innovations are intended to improve outcomes for patients at risk of Chronic Kidney Disease (CKD) by enabling healthcare providers to monitor and reduce the use of contrast dye effectively.